This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jeamwattanalert, P.
Right arrow Articles by Hirunpetcharat, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jeamwattanalert, P.
Right arrow Articles by Hirunpetcharat, C.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, April 2007, p. 342-347, Vol. 14, No. 4
1071-412X/07/$08.00+0     doi:10.1128/CVI.00397-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Long-Lasting Protective Immune Response to the 19-Kilodalton Carboxy-Terminal Fragment of Plasmodium yoelii Merozoite Surface Protein 1 in Mice{triangledown}

Pimmada Jeamwattanalert,1 Yuvadee Mahakunkijcharoen,2 Leera Kittigul,1 Pakpimol Mahannop,3 Sathit Pichyangkul,4 and Chakrit Hirunpetcharat1*

Department of Microbiology, Faculty of Public Health,1 Department of Microbiology and Immunology, Faculty of Tropical Medicine,2 Department of Parasitology, Faculty of Public Health, Mahidol University, Bangkok, Thailand,3 Department of Immunology and Medicine, U.S. Armed Forces Research Institute of Medical Science, Bangkok, Thailand4

Received 20 October 2006/ Returned for modification 22 December 2006/ Accepted 8 February 2007

Merozoite surface protein 1 (MSP1) is the major protein on the surface of the plasmodial merozoite, and its carboxy terminus, the 19-kDa fragment (MSP119), is highly conserved and effective in induction of a protective immune response against malaria parasite infection in mice and monkeys. However, the duration of the immune response has not been elucidated. As such, we immunized BALB/c mice with a standard four-dose injection of recombinant Plasmodium yoelii MSP119 formulated with Montanide ISA51 and CpG oligodeoxynucleotide (ODN) and monitored the MSP119-specific antibody levels for up to 12 months. The antibody titers persisted constantly over the period of time without significant waning, in contrast to the antibody levels induced by immunization with Freund's adjuvant, where the antibody levels gradually declined to significantly lower levels 12 months after immunization. Investigation of immunoglobulin G (IgG) subclass longevity revealed that only the IgG1 antibody level (Th2 type-driven response) decreased significantly by 6 months, while the IgG2a antibody level (Th1 type-driven response) did not change over the 12 months after immunization, but the boosting effect was seen in the IgG1 antibody responses but not in the IgG2a antibody responses. After challenge infection, all immunized mice survived with negligibly patent parasitemia. These findings suggest that protective immune responses to MSP119 following immunization using oil-based Montanide ISA51 and CpG ODN as an adjuvant are very long-lasting and encourage clinical trials for malaria vaccine development.

* Corresponding author. Mailing address: Department of Microbiology, Faculty of Public Health, Mahidol University, 420/1 Rajvithi Road, Bangkok 10400, Thailand. Phone: (662) 3548528, ext. 104. Fax: (662) 3548538. E-mail: phchr{at}mahidol.ac.th

{triangledown} Published ahead of print on 21 February 2007.

Clinical and Vaccine Immunology, April 2007, p. 342-347, Vol. 14, No. 4
1071-412X/07/$08.00+0     doi:10.1128/CVI.00397-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»